| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANKRD6
|
ankyrin repeat domain 6
|
|
AR
|
androgen receptor
|
|
ATM
|
ATM serine/threonine kinase
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
|
CD19
|
CD19 molecule
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD6
|
CD6 molecule
|
|
CHEK2
|
checkpoint kinase 2
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DNM1L
|
dynamin 1-like
|
|
DUT
|
deoxyuridine triphosphatase
|
|
EFNB1
|
ephrin-B1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
FCRL3
|
Fc receptor-like 3
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXO1
|
forkhead box O1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
JAK2
|
Janus kinase 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
LIPE
|
lipase, hormone-sensitive
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
PDCD10
|
programmed cell death 10
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER2
|
period circadian clock 2
|
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
|
|
PITPNB
|
phosphatidylinositol transfer protein, beta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RBM17
|
RNA binding motif protein 17
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RNPS1
|
RNA binding protein S1, serine-rich domain
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SPACA1
|
sperm acrosome associated 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
SYN3
|
synapsin III
|
|
TARDBP
|
TAR DNA binding protein
|
|
TH
|
tyrosine hydroxylase
|
|
TP53
|
tumor protein p53
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TTN
|
titin
|